• Home
• Our mission and strategy
• Deliver more products of value

Deliver more
products of value

We are striving to build one of the strongest pipelines in the industry. We are transforming R&D to ensure that we not only deliver the current pipeline but are also able to sustain a flow of new products for years to come.

As we move towards a more diversified business we will concentrate on developing a higher volume of mid-size products for more clearly-defined patient populations. This will help develop a lower risk portfolio which is not dependent on the performance of one or two large products.

Positive steps have already been taken, with 30 late-stage assets currently in our pharmaceuticals and vaccines pipeline. Our objective is to sustain this throughput of products over the long-term.

Our plans

• Focus on the best science
• Diversify through externalisation
• Re-personalise R&D
• Focus on return on investment

• Find out more about these plans

“To be successful in the healthcare marketplace in the next few years its all going to be about delivering value.”